Citations (37)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Amin Gasmi, Geir Bjørklund, Sadaf Noor, Yuliya Semenova, Alexandru Dosa, Joeri J. Pen, Alain Menzel, Salva Piscopo, Nicolas Wirth & Daniel-Ovidiu Costea. (2023) Nutritional and surgical aspects in prostate disorders. Critical Reviews in Food Science and Nutrition 63:21, pages 5138-5154.
Read now
Read now
Dexter Puckett, Mohammed Alquraishi, Dina S. Alani, Samah Chahed, Victoria D. Frankel, Dallas Donohoe, Brynn Voy, Jay Whelan & Ahmed Bettaieb. (2020) Zyflamend, a unique herbal blend, induces cell death and inhibits adipogenesis through the coordinated regulation of PKA and JNK. Adipocyte 9:1, pages 454-471.
Read now
Read now
Yanshi Xue, Lin Yang, Junzun Li, Yilin Yan, Qinghui Jiang, Lan Shen, Shuai Yang, Bing Shen, Ruimin Huang, Jun Yan & Hongqian Guo. (2018) Combination chemotherapy with Zyflamend reduced the acquired resistance of bladder cancer cells to cisplatin through inhibiting NFκB signaling pathway. OncoTargets and Therapy 11, pages 4413-4429.
Read now
Read now
E.-Chu Huang, MichaelF. McEntee & Jay Whelan. (2012) Zyflamend, a Combination of Herbal Extracts, Attenuates Tumor Growth in Murine Xenograft Models of Prostate Cancer. Nutrition and Cancer 64:5, pages 749-760.
Read now
Read now
E-Chu Huang, Guoxun Chen, Seung
Joon Baek, MichaelF. McEntee, J.
Jason Collier, Steven Minkin, John Biggerstaff & Jay Whelan. (2011) Zyflamend Reduces the Expression of Androgen Receptor in a Model of Castrate-Resistant Prostate Cancer. Nutrition and Cancer 63:8, pages 1287-1296.
Read now
Read now
Suhendan Ekmekcioglu, Chandrani Chattopadhyay
, Ugur Akar
, Abdul Gabisi$suffix/text()$suffix/text(), RobertA. Newman & ElizabethA. Grimm. (2011) Zyflamend Mediates Therapeutic Induction of Autophagy to Apoptosis in Melanoma Cells. Nutrition and Cancer 63:6, pages 940-949.
Read now
Read now
SantoshK. Sandur, Kwang
Seok Ahn, Haruyo Ichikawa, Gautam Sethi, Shishir Shishodia, RobertA. Newman & BharatB. Aggarwal. (2007) Zyflamend, a Polyherbal Preparation, Inhibits Invasion, Suppresses Osteoclastogenesis, and Potentiates Apoptosis Through Down-Regulation of NF-κ B Activation and NF-κ B–Regulated Gene Products. Nutrition and Cancer 57:1, pages 78-87.
Read now
Read now
Debra L Bemis, Aaron E Katz & Ralph Buttyan. (2006) Clinical trials of natural products as chemopreventive agents for prostate cancer. Expert Opinion on Investigational Drugs 15:10, pages 1191-1200.
Read now
Read now
Articles from other publishers (29)
Bingke Bai, Qianbo Chen, Rui Jing, Xuhui He, Hongrui Wang, Yanfei Ban, Qi Ye, Weiheng Xu & Chengjian Zheng. (2021) Molecular Basis of Prostate Cancer and Natural Products as Potential Chemotherapeutic and Chemopreventive Agents. Frontiers in Pharmacology 12.
Crossref
Crossref
Dexter L. Puckett, Mohammed Alquraishi, Dina Alani, Samah Chahed, Dallas Donohoe, Brynn Voy, Jay Whelan & Ahmed Bettaieb. (2020) Zyflamend induces apoptosis in pancreatic cancer cells via modulation of the JNK pathway. Cell Communication and Signaling 18:1.
Crossref
Crossref
Michael R Buckley, Paul D Terry, Stacy S Kirkpatrick, Joshua D Arnold, Michael M McNally, Oscar H Grandas, Michael B Freeman, Mitchell H Goldman, Jay Whelan & Deidra JH Mountain. (2019) Dietary supplementation with Zyflamend poly-herbal extracts and fish oil inhibits intimal hyperplasia development following vascular intervention. Nutrition Research 68, pages 34-44.
Crossref
Crossref
Amber F. MacDonald, Ahmed Bettaieb, Dallas R. Donohoe, Dina S. Alani, Anna Han, Yi Zhao & Jay Whelan. (2018) Concurrent regulation of LKB1 and CaMKK2 in the activation of AMPK in castrate-resistant prostate cancer by a well-defined polyherbal mixture with anticancer properties. BMC Complementary and Alternative Medicine 18:1.
Crossref
Crossref
Eric D. TagueAllen K. BourdonAmber MacDonaldMaggie S. LookadooEdward D. KimWesley M. WhitePaul D. TerryShawn R. CampagnaBrynn H. VoyJay Whelan. (2018) Metabolomics Approach in the Study of the Well-Defined Polyherbal Preparation Zyflamend. Journal of Medicinal Food 21:3, pages 306-316.
Crossref
Crossref
Priyadarshini & Abhishek Negi. 2018. Anticancer plants: Properties and Application. Anticancer plants: Properties and Application
539
558
.
Thierry Roumeguère, Joseph Sfeir, Elie El Rassy, Simone Albisinni, Pierre Van Antwerpen, Karim Zouaoui Boudjeltia, Nassim Farès, Joseph Kattan & Fouad Aoun. (2017) Oxidative stress and prostatic diseases. Molecular and Clinical Oncology 7:5, pages 723-728.
Crossref
Crossref
Michelle Bratton. 2017. Integrating Nutrition Into Practice. Integrating Nutrition Into Practice
231
250
.
Jay Whelan, Yi Zhao, E-Chu Huang, Amber MacDonald & Dallas Donohoe. 2016. Complementary and Alternative Medicines in Prostate Cancer. Complementary and Alternative Medicines in Prostate Cancer
197
220
.
Yi Zhao, Dallas Donohoe, E-Chu Huang & Jay Whelan. (2015) Zyflamend, a polyherbal mixture, inhibits lipogenesis and mTORC1 signalling via activation of AMPK. Journal of Functional Foods 18, pages 147-158.
Crossref
Crossref
Michelle BrattonRDNRDN. 2015. Integrative Nutrition Therapy. Integrative Nutrition Therapy
231
250
.
Mehmet Asim Bilen, Sue-Hwa Lin, Dean G. Tang, Kinjal Parikh, Mong-Hong Lee, Sai-Ching J. Yeung & Shi-Ming Tu. (2015) Maintenance Therapy Containing Metformin and/or Zyflamend for Advanced Prostate Cancer: A Case Series. Case Reports in Oncological Medicine 2015, pages 1-5.
Crossref
Crossref
E-Chu Huang, Yi Zhao, Guoxun Chen, Seung Joon Baek, Michael F McEntee, Steven Minkin, John P Biggerstaff & Jay Whelan. (2014) Zyflamend, a polyherbal mixture, down regulates class I and class II histone deacetylases and increases p21 levels in castrate-resistant prostate cancer cells. BMC Complementary and Alternative Medicine 14:1.
Crossref
Crossref
Yasuhito Funahashi, Katherine J. O'Malley, Naoki Kawamorita, Pradeep Tyagi, Donald B. DeFranco, Ryosuke Takahashi, Momokazu Gotoh, Zhou Wang & Naoki Yoshimura. (2014) Upregulation of androgen-responsive genes and transforming growth factor-β1 cascade genes in a rat model of non-bacterial prostatic inflammation. The Prostate 74:4, pages 337-345.
Crossref
Crossref
Yiannis Philippou, Marios Hadjipavlou, Shahid Khan & Abhay Rane. (2013) Complementary and alternative medicine (CAM) in prostate and bladder cancer. BJU International 112:8, pages 1073-1079.
Crossref
Crossref
Sanjeev Banerjee, Asfar Azmi, Bin Bao & Fazlul H. Sarkar. 2013. Cancer Chemoprevention and Treatment by Diet Therapy. Cancer Chemoprevention and Treatment by Diet Therapy
269
310
.
Philippa J. Cheetham & Aaron E. Katz. 2013. Prostate Cancer: A Comprehensive Perspective. Prostate Cancer: A Comprehensive Perspective
355
367
.
Ajaikumar B. Kunnumakkara, Bokyung Sung, Jayaraj Ravindran, Parmeswaran Diagaradjane, Amit Deorukhkar, Sanjit Dey, Cemile Koca, Zhimin Tong, Juri G. Gelovani, Sushovan Guha, Sunil Krishnan & Bharat B. Aggarwal. (2012) Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets. International Journal of Cancer 131:3, pages E292-E303.
Crossref
Crossref
María Gómez-Serranillos Cuadrado, María Ortega Hernández-Agero, Olga Palomino Ruiz-Poveda & María Carretero Accame. 2012. Medicinal Plants. Medicinal Plants
412
471
.
Samuel J. Klempner & Glenn Bubley. (2012) Complementary and Alternative Medicines in Prostate Cancer: From Bench to Bedside?. The Oncologist 17:6, pages 830-837.
Crossref
Crossref
Jun Yan, Bingxian Xie, Jillian L. Capodice & Aaron E. Katz. (2012) Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth. The Prostate 72:3, pages 244-252.
Crossref
Crossref
Xiaoqiang Xu, Xiuhong Gao, Linhong Jin, Pinaki S Bhadury, Kai Yuan, Deyu Hu, Baoan Song & Song Yang. (2011) Antiproliferation and cell apoptosis inducing bioactivities of constituents from Dysosma versipellis in PC3 and Bcap-37 cell lines. Cell Division 6:1.
Crossref
Crossref
Nicole Birgit Arweiler, Gregory Pergola, Jana Kuenz, Elmar Hellwig, Anton Sculean & Thorsten Mathias Auschill. (2010) Clinical and antibacterial effect of an anti-inflammatory toothpaste formulation with Scutellaria baicalensis extract on experimental gingivitis. Clinical Oral Investigations 15:6, pages 909-913.
Crossref
Crossref
Aaron Katz. 2010. Early Diagnosis and Treatment of Cancer Series: Prostate Cancer. Early Diagnosis and Treatment of Cancer Series: Prostate Cancer
207
228
.
Geovanni Espinosa & Aaron Katz. 2009. Food and Nutrients in Disease Management. Food and Nutrients in Disease Management.
Peiying Yang, Zheng Sun, Diana Chan, Carrie A. Cartwright, Mary Vijjeswarapu, Jibin Ding, Xiaoxin Chen & Robert A. Newman. (2008) Zyflamend® reduces LTB 4 formation and prevents oral carcinogenesis in a 7,12-dimethylbenz[α]anthracene (DMBA)-induced hamster cheek pouch model. Carcinogenesis 29:11, pages 2182-2189.
Crossref
Crossref
James A. (Jim) Duke. (2007) The Garden Pharmacy: Turmeric, the Queen of COX-2-Inhibitors. Alternative and Complementary Therapies 13:5, pages 229-234.
Crossref
Crossref
Chapla Agarwal, Alpna Tyagi, Manjinder Kaur & Rajesh Agarwal. (2007) Silibinin inhibits constitutive activation of Stat3, and causes caspase activation and apoptotic death of human prostate carcinoma DU145 cells. Carcinogenesis 28:7, pages 1463-1470.
Crossref
Crossref
Samuil Rafailov, Sam Cammack, Brian A. Stone & Aaron E. Katz. (2016) The Role of Zyflamend, an Herbal Anti-inflammatory, as a Potential Chemopreventive Agent Against Prostate Cancer: A Case Report. Integrative Cancer Therapies 6:1, pages 74-76.
Crossref
Crossref